INDICATION:Wynzora®(calcipotriene and betamethasone dipropionate) Cream, 0.005%/0.064% is indicated for the topical treatment of plaque psoriasis in patients 18 years of age and older.ADVERSE EVENTS:In the pivotal trial, the most common adverse reactions (≥1%) were: upper respiratory infection ...